Ology Bio

Alachua, United States Founded: 1999 • Age: 27 yrs Acquired By Resilience
Biologics-focused contract development and manufacturing organization (CDMO)
Request Access

About Ology Bio

Ology Bio is a company based in Alachua (United States) founded in 1999 was acquired by Resilience in April 2021.. Ology Bio operates in a competitive market with competitors including KBI Biopharma, Aldevron, Eurogentec, EirGenix and Ovagen, among others.

  • Headquarter Alachua, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $8.4 M (USD), Grant

    Aug 01, 2018

  • Investors
    NIH

    & 8 more

  • Employee Count
    Employee Count
  • Acquired by
    Resilience

    (Apr 12, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Ology Bio
Headcount 1-10
Employee Profiles 8
Board Members and Advisors 16
Employee Profiles
People
Junan Guo
Chief Quality Officer
People
William S. Marth
President & CEO
People
Jimmy Wang
Chief Information Officer
People
Andrew Montone
Chief Financial Officer, Interim

Unlock access to complete

Board Members and Advisors
people
Robert Nelsen
Chairman
people
Beverly L. Davidson
Advisor
people
Mark McClellan
Advisor
people
George Barrett
Board Member

Unlock access to complete

Funding Insights of Ology Bio

  • Total Funding
  • Total Rounds 7
  • Last Round Grant — $8.4M
  • First Round
  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2018 Amount Grant - Ology Bio Valuation

investors

Mar, 2018 Amount Private Equity Round - Ology Bio Valuation

investors

Mar, 2015 Amount Debt – Conventional - Ology Bio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ology Bio

Ology Bio has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Hercules Capital and US Navy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Venture debt and equipment financing are provided to growth-stage companies.
Founded Year Domain Location
Venture debt financing is provided to companies in multiple sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ology Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ology Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ology Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ology Bio

Ology Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Eurogentec, EirGenix and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of protein formulation, process & cell line development, and cGMP services
domain founded_year HQ Location
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
domain founded_year HQ Location
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
domain founded_year HQ Location
Biologics development and manufacturing services are offered by EirGenix.
domain founded_year HQ Location
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
domain founded_year HQ Location
Precision fermentation services for biopharma and food are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ology Bio

Frequently Asked Questions about Ology Bio

When was Ology Bio founded?

Ology Bio was founded in 1999 and raised its 1st funding round 6 years after it was founded.

Where is Ology Bio located?

Ology Bio is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.

Who is the current CEO of Ology Bio?

Peter Khoury is the current CEO of Ology Bio.

What does Ology Bio do?

Ology Bioservices (formerly Nanotherapeutics) is a biologics-focused contract development and manufacturing organization (CDMO) serving both government and commercial clients. It offers services such as process development, cell line development, cGMP manufacturing, analytical regulatory for recombinant proteins, monoclonal antibodies, viral vaccines, and gene therapy drug products. The company has developed proprietary vaccine delivery technologies and platform expression systems. The company uses their proprietary Vero Cell vaccine manufacturing cell line acquired from BaxaltaBaxter Vaccines for the development of inactivated whole virus vaccines. It offers mammalian cell line development capabilities. The company has a BSL-3 cGMP compliant vaccines manufacturing facility called Advanced Development and Manufacturing (ADM) facility. The company has several vaccine programs available for partnering andor licensing such as ross river (phase III), chikungunya, pandemic and seasonal flu vaccines, yellow fever (MVA), typhoid, West Nile and norovirus.

Who are the top competitors of Ology Bio?

Ology Bio's top competitors include KBI Biopharma, Aldevron and Ovagen.

Who are Ology Bio's investors?

Ology Bio has 9 investors. Key investors include NIH, Hercules Capital, US Navy, Resilience, and DARPA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available